- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 3, 2024 | 60.09M sh |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $105.79M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $108.67M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $19.03M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $24.7M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $46.01M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $54.2M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $158.36M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $178.78M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $182.98M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $213.28M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $64.33M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $61.65M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 57.15M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $126K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$5.95M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $225.61M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $244.5M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.46 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.46 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $10.06M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $19.66M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$26.24M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$28.49M |
| Revenue | Q1 2024 · Mar 31, 2023 | $1.22M |